SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Every student deserves a personal tutor, inside the classroom, too.

AI companies say their models are the best. Here's how to tell if that's true

What if the AI runs out of electricity?

Intel shares plunge 25% as weak forecast rattles investors

Buzz

Most popular

Daily

Weekly

1

"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce

2

Intel shares plunge as Israel factory blast compounds weak outlook

3

Cyber startup Cyera eyes $20 billion valuation in new funding talks

4

Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief

5

Nikesh Arora's pay falls 19.5% to $80 million as Palo Alto Networks board lowers cap on stock awards

Blood Cancer

4 stories about Blood Cancer

אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy

Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer

The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000